Purchases and Sales Made in Q4 2022 in Jounce Therapeutics, Inc. (JNCE)
This table provides information about the institutional ownership of Jounce Therapeutics, Inc. (JNCE) during Q4 2022. The information is specifically focused on institutions that hold shares of Jounce Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-4.73K- 0.72% |
$3.02K - $9.4K
|
648K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-5K- 3.05% |
$3.2K - $9.95K
|
159K
$0
|
|
|
Jan 31, 2023
Q4 2022
|
Kestra Advisory Services, LLC
|
SELL
|
- |
-10.3K- 28.2% |
$6.56K - $20.4K
|
26.1K
$0
|
|
|
Feb 07, 2023
Q4 2022
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-14.4K- 57.24% |
$9.2K - $28.6K
|
10.7K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-16.6K- 6.84% |
$10.6K - $33K
|
226K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-20.5K- 1.22% |
$13.1K - $40.8K
|
1.66M
$0
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-34.8K- 21.53% |
$22.3K - $69.2K
|
127K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-34.8K- 21.53% |
$22.3K - $69.2K
|
127K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-44.2K- 45.54% |
$28.3K - $87.9K
|
52.8K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-52.5K- 53.91% |
$33.6K - $104K
|
44.8K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-62.7K- 12.35% |
$40.1K - $125K
|
445K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Panagora Asset Management Inc
Boston, MA |
SELL
|
- |
-104K- 72.22% |
$66.7K - $207K
|
40.1K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-183K- 94.67% |
$117K - $365K
|
10.3K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-218K- 7.81% |
$139K - $434K
|
2.57M
$0
|
|
|
Jan 12, 2023
Q4 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-278K- 34.7% |
$178K - $553K
|
523K
$0
|
|
|
Feb 09, 2023
Q4 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-292K- 28.97% |
$187K - $580K
|
715K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.45M- 99.39% |
$926K - $2.88M
|
8.94K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-3.75M- 91.55% |
$2.4M - $7.46M
|
346K
$0
|